Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

about

Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

Item

http://www.wikidata.org/entity/Q50056652

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

@en

Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

@nl

type

Item

label

Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

@en

Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

@nl

prefLabel

Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

@en

Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

@nl

P1476

Targeted mRNA Therapy for Ornithine Transcarbamylase Deficiency.

@en

P2093

Allen G Li

http://www.w3.org/2001/XMLSchema#string

Amber E Paschal

http://www.w3.org/2001/XMLSchema#string

Anna Galperin

http://www.w3.org/2001/XMLSchema#string

Debashish Roy

http://www.w3.org/2001/XMLSchema#string

Eric C Bell

http://www.w3.org/2001/XMLSchema#string

Jean-Rene Ella-Menye

http://www.w3.org/2001/XMLSchema#string

Mary G Prieve

http://www.w3.org/2001/XMLSchema#string

Matt Waldheim

http://www.w3.org/2001/XMLSchema#string

Michael E Houston

http://www.w3.org/2001/XMLSchema#string

Pierrot Harvie

http://www.w3.org/2001/XMLSchema#string

P2860

Suppression of RNA recognition by Toll-like receptors: the impact of nucleoside modification and the evolutionary origin of RNA

Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential

Viral vectors: a look back and ahead on gene transfer technology

Why is start codon selection so precise in eukaryotes?

Recombinant messenger RNA technology and its application in cancer immunotherapy, transcript replacement therapies, pluripotent stem cell induction, and beyond

Efficient hepatic delivery of drugs: novel strategies and their significance

Fatal systemic inflammatory response syndrome in a ornithine transcarbamylase deficient patient following adenoviral gene transfer

The many pathways of RNA degradation

Successful transduction of liver in hemophilia by AAV-Factor IX and limitations imposed by the host immune response

pH-responsive polymeric micelle carriers for siRNA drugs.

P31

scholarly article

P356

10.1016/J.YMTHE.2017.12.024

http://www.w3.org/2001/XMLSchema#string

P577

2018-01-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29433939

http://www.w3.org/2001/XMLSchema#string

P932

5910669

http://www.w3.org/2001/XMLSchema#string